PLK1 and neoplasm: IHC results showed that the combination of exogenous proline and cisplatin significantly reduced the staining of PLK1 in A549/CDDP tumour xenograft compared with their individual effects (Figure 4G, Supplementary Figure S9F, Supplementary Figure S9G).